Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Whereas an impaired ability to oxidize fatty acids is thought to contribute to intracellular lipid accumulation, insulin resistance, and cardiac dysfunction, high rates of fatty acid oxidation could also impair glucose metabolism and function. We therefore determined the effects of diet-induced obesity (DIO) in wild-type (WT) mice and mice deficient for malonyl CoA decarboxylase (MCD−/−; an enzyme promoting mitochondrial fatty acid oxidation) on insulin-sensitive cardiac glucose oxidation. RESEARCH DESIGN AND METHODS: WT and MCD−/− mice were fed a low- or high-fat diet for 12 weeks, and intramyocardial lipid metabolite accumulation was assessed. A parallel feeding study was performed to assess myocardial function and energy metabolism (nanomoles per gram of dry weight per minute) in isolated working hearts (+/– insulin). RESULTS: DIO markedly reduced insulin-stimulated glucose oxidation compared with low fat–fed WT mice (167 ± 31 vs. 734 ± 125; P < 0.05). MCD−/− mice subjected to DIO displayed a more robust insulin-stimulated glucose oxidation (554 ± 82 vs. 167 ± 31; P < 0.05) and less incomplete fatty acid oxidation, evidenced by a decrease in long-chain acylcarnitines compared with WT counterparts. MCD−/− mice had long-chain acyl CoAs similar to those of WT mice subjected to DIO but had increased triacylglycerol levels (10.92 ± 3.72 vs. 3.29 ± 0.62 μmol/g wet wt; P < 0.05). CONCLUSIONS: DIO does not impair cardiac fatty acid oxidation or function, and there exists disassociation between myocardial lipid accumulation and insulin sensitivity. Our results suggest that MCD deficiency is not detrimental to the heart in obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Loss of MCD results in partial CPT1 inhibition [50,88].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [88]
In the citing paper
“the mcd−/− mice had decreased acylcarnitine accumulation in muscle, enhanced rates of glucose oxidation, and resisted diet-induced glucose intolerance, despite high intramuscular levels of triacylglycerol and long chain acyl-CoAs [50,88].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311 · cited 1×
“The incidence of obesity, insulin resistance, and diabetes is rapidly increasing (1–4), and by 2025 it is estimated that worldwide the incidence of diabetes will affect nearly 333 million individuals between 20 and 79 years of age (4).”
BackgroundCellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990 · cited 10×
“Recent studies have suggested that accumulation of intermediates of incomplete fatty acid oxidation correlate with skeletal muscle insulin resistance (11,25,26).”
BackgroundMethodResultInfluentialSelf-citationThe worldwide obesity epidemic
James, P. T., Leach, R., Kalamara, E., & Shayeghi, M. (2001) · Obesity Research · doi:10.1038/oby.2001.123 · Cited by 1,201 · cited 1×
“3 he incidence of obesity, insulin resistance, and diabetes is rapidly increasing (1-4), and by 2025 it is estimated that worldwide the incidence of diabetes will affect nearly 333 million individuals between 20 and 79 years of age (41).”
BackgroundGoodpaster, B. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5755 · Cited by 1,194 · cited 1×
“Further support for this concept lies in the athletes’ paradox, in which endurance-trained individuals have greater muscle insulin sensitivity despite greater levels of intramuscular triacylglycerols (38,39).”
BackgroundMolecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
Self-citationDisordered lipid metabolism and the pathogenesis of insulin resistance.
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107 · cited 1×
“While there is a general consensus that increased circulating fatty acids lead to increased rates of fatty acid uptake in muscle, the contribution of impaired mitochondrial fatty acid oxidation to the accumulation of cytosolic intramuscular fatty acid metabolites implicated in the pathogenesis of insulin resistance (s…”
BackgroundThe cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
Self-citationUnger, R. H. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104057 · Cited by 875 · cited 1×
“While there is a general consensus that increased circulating fatty acids lead to increased rates of fatty acid uptake in muscle, the contribution of impaired mitochondrial fatty acid oxidation to the accumulation of cytosolic intramuscular fatty acid metabolites implicated in the pathogenesis of insulin resistance (s…”
BackgroundEtiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 2×
“It has been suggested that an impairment in the mitochondrial uptake and subsequent oxidation of fatty acids contribute to the accumulation of intramuscular acyl CoAs and the development of insulin resistance (6,8,15) and myocardial dysfunction (16,17,20).”
Background
Cited by
Items 101–135 of 135
Pedersen, T. M., Boardman, N. T., Hafstad, A. D., & Aasum, E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204843 · Cited by 14
Long-chain free fatty acids inhibit ischaemic preconditioning of the isolated rat heart
Lochner, A., Genade, S., Genis, A., Marais, E., & Salie, R. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03812-9 · Cited by 12
Chemical-genetic induction of Malonyl-CoA decarboxylase in skeletal muscle
Rodriguez, S., Ellis, J. M., & Wolfgang, M. J. (2014) · BMC Biochemistry · doi:10.1186/1471-2091-15-20 · Cited by 11
Meng, Y., Ding, P., Wang, H., Yang, X., Wang, Z., Nie, D., Liu, J., Huang, Y. L., Su, G., Hu, J., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159120 · Cited by 12
Role of Warburg Effect in Cardiovascular Diseases: A Potential Treatment Option
kuspriyanti, N. P., Ariyanto, E. F., & Syamsunarno, M. R. A. A. (2021) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192402115010006 · Cited by 10
“Other studies have shown that FA oxidation stimulation and oxidative phosphorylation improve HF [11, 14, 60].”
BackgroundDakhili, S. A. T., Greenwell, A. A., & Ussher, J. R. (2023) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2023.12.1.47 · Cited by 10
Self-citationSun, W., Quan, N., Wang, L., Yang, H., Chu, D., Liu, Q., Zhao, X., Leng, J., & Li, J. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw154 · Cited by 8
“Enhancing glucose oxidation can significantly reduce infarct size (Ma et al., 2015; Ussher et al., 2009; Wang et al., 2013).”
BackgroundLipotoxicity in Diabetic Cardiomyopathy: Molecular Basis and Emerging Therapeutic Targets
Han, Y., Chen, X., Fonseka, O., & Liu, W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062740 · Cited by 7
“MCD knockout mice hearts displayed significantly higher glucose oxidation levels and less lipid intermediates compared to wild-type mice, following a low-fat diet for 12 weeks [130].”
Rahim, M., Bednarski, T. K., Hasenour, C. M., Banerjee, D. R., Trenary, I. A., & Young, J. D. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115591 · Cited by 6
“52,53 This hypothesis stems largely from work performed in isolated hearts or cultured cardiomyocytes with glucose and palmitate as the sole substrates.”
Cardiac substrate metabolism in type 2 diabetes
Chan, J. S. F., Shafaati, T., & Ussher, J. R. (2025) · Biochemical Journal · doi:10.1042/bcj20240189 · Cited by 9
“In support of this, many KO mouse models (e.g., MCD KO mice and PPAR KO mice) that result in decreased cardiac fatty acid oxidation combined with increased cardiac TAG/lipid accumulation paralleling that observed in obesity/T2D exhibit normal cardiac function [94,104].”
Self-citationCardiac Insulin Resistance: It's Sweeter Than You Think
Ussher, J. R., & Lopaschuk, G. D. (2013) · Endocrinology · doi:10.1210/en.2013-1506 · Cited by 6
Self-citationTargeting MicroRNAs to Limit Myocardial Lipid Accumulation
Lopaschuk, G. D., & Ussher, J. R. (2015) · Circulation Research · doi:10.1161/circresaha.114.305675 · Cited by 6
Self-citationMolecular Targets and Small Molecules Modulating Acetyl Coenzyme A in Physiology and Diseases
Ewida, H. A., Benson, H., Tareq, S., & Ahmed, M. S. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00476 · Cited by 5
Goodman, J., Schain, M., Stefano, G. D., Lupson, V. C., Horn, T., Hill, M., Manavaki, R., Fryer, T. D., Bumanlag-Amis, E., Jalaludeen, N., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-04559-3 · Cited by 5
“Physiologically, insulin secretion is enhanced by GLP-1 receptor agonists and is shown to act as a potent stimulator of cardiac glucose metabolism and glucose oxidation 60 .”
Chan, J. S. F., Dong, L., & Ussher, J. R. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00063.2025 · Cited by 4
Self-citationGuzmán‐Ruiz, R., Gómez‐Hurtado, N., Gil‐Ortega, M., Somoza, B., González, M. C., Aránguez, I., Martín-Ramos, M., González‐Martín, C., Delgado, C., Fernández‐Alfonso, M. S., et al. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00175 · Cited by 5
The Role of Incomplete Fatty Acid β-Oxidation in the Development of Cardiac Insulin Resistance
Ussher, J. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1227-8_14 · Cited by 5
Self-citationFNDC4 Prevents Aging-Related Cardiac Dysfunction
Zhang, X., Dong, W.-S., Li, K., Ye, Y.-J., & Hu, C. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.01.004 · Cited by 4
Jagdale, D. M., & Ramaa, C. S. (2017) · Medicinal Chemistry Research · doi:10.1007/s00044-017-1917-7 · Cited by 3
“(Dyck et al. 2006; Ussher et al. 2009).”
An ACE Up Your Sleeve: 2 Is Better Than 1
Ussher, J. R., & Lopaschuk, G. D. (2012) · Circulation Research · doi:10.1161/circresaha.112.269951 · Cited by 3
Self-citationIncretin-mediated control of cardiac energy metabolism
Chan, J. S. F., Shafaati, T., & Ussher, J. R. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0011 · Cited by 2
Self-citationMolecular Changes in Fatty Acid Oxidation in the Failing Heart
Jaswal, J. S., Keung, W., Wang, W., Ussher, J. R., & Lopaschuk, G. D. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7130-2_12 · Cited by 2
Self-citationYu, H., Chang, S.-Y., Tian, X., Xiao, H. R., Xu, J., Zhu, C.-L., Li, D., & Xu, L. (2025) · Current Heart Failure Reports · doi:10.1007/s11897-025-00731-y · Cited by 1
Malonyl-CoA Decarboxylase: A Spotlight on Brain Aspects
Fonseca-Teixeira, M., Brito, E. S., Beltrao-Valente, C., Ferreira, B. K., Schuck, P. F., & Ferreira, G. C. (2026) · Brain Sciences · doi:10.3390/brainsci16020220 · Cited by 1
“MCD modulation is implicated in the pathophysiology of different metabolic diseases, including obesity and diabetes [8–10].”
Nduhirabandi, F. (2014) · SUNScholar (Stellenbosch University)
The Canadian Diabetes Association Invests More Than $6.8 million in Research
VandenBerg, P., & Verchere, C. B. (2009) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(09)33004-x
Role of Lysine Acetylation in the Control of Cardiac Energy Metabolism
Alrub, A. (2014) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3g15tk4x
Metabolic efficiency in remodeled failing hearts
Masoud, W. G. T. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r39s1ks1s
Cardiac Energy Metabolism in Heart Failure Associated with Obesity and Diabetes
Lopaschuk, G. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1227-8_5 · Cited by 2
Self-citationGLP-1R Agonists & Cardiac Energy Metabolism in Type 2 Diabetes
Almutairi, M. G. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-fhr3-cr50
Current literature in diabetes
(2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1015
Cotter, G., & Milo, O. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1166999.629112
The Canadian Diabetes Association Invests More than $7 Million in Research
VandenBerg, P. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.07.011
van Rinsum, A., Hu, L., Qi, X., Turan, G., Zhang, J., Dekker, S. O., de Vries, A. A. F., Keijer, J., & Zhang, D. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168373
Metadata
- Authors
- Ussher, J. R., Koves, T. R., Jaswal, J. S., Zhang, L., Ilkayeva, O., Dyck, J. R. B., Muoio, D. M., & Lopaschuk, G. D.
- Affiliations
- University of Alberta (CA)
- Duke University (US)
- Corresponding author
- Lopaschuk, Gary D.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-05-28
- Volume
- 58
- Issue
- 8
- Pages
- 1766-1775
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2712785
- OpenAlex
- W2098822834
- Cited by
- 135
- References
- 45
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 7 · 2020: 5 · 2019: 2 · 2018: 9 · 2017: 7 · 2016: 11 · 2015: 8 · 2014: 19 · 2013: 9 · 2012: 18
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Update notices
- correction (2009-10-01)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- malonyl-CoA decarboxylase, insulin resistance, diet-induced obesity, high-fat diet, fatty acid oxidation, myocardial lipid accumulation, triglycerides, acylcarnitines, acyl-CoA, myocardial energy metabolism, cardiac function
- MeSH terms
- Animals, Carboxy-Lyases, Dietary Fats, Glucose, Heart, Insulin, Mice, Obese, Myocardium, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.